PTCD1 and bladder transitional cell carcinoma: We divided the patients in TCGA-BLCA data set into G1 (stages I-II) and G2 (stages III-IV) and found that the expression of PTCD1 in G2 group was importantly lower than that in G1 group (Figure 1(e)).